Scrip
Antisoma losses widen in 'challenging' year
29 July 2010
Peter Mansell
Please Login to read the full article.
29 July 2010
Peter Mansell
In a difficult financial year dominated by the failure of its lead anticancer candidate ASA404, Antisoma reported a net loss of £18.7 million, or 3.0p per diluted share, compared with a £16.4 million loss, or 2.7p per diluted share, in the year ended 30 June.
Revenues for the...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Recipharm sees opportunity to ride wave of CDMO consolidation
- GW high on pipeline of cannabis extracts
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
